Pharmacoresistance with newer anti-epileptic drugs in mesial temporal lobe epilepsy with hippocampal sclerosis.
Epilepsy Research（2017）
Abstract
•The majority (75.3%) of patients with MTLE-HS remain refractory to 2 or more appropriate AED trials.•Newer AEDs are not more likely to control seizures in MTLE-HS than older AEDs.•Duration of epilepsy significantly correlates with number of AED trials in seizure free but not pharmacoresistant patients.
MoreTranslated text
Key words
Anti-epileptic drugs,Epilepsy surgery,Hippocampal sclerosis,Natural history studies (prognosis),MRI
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined